C
Carolyn E. Mountford
Researcher at Translational Research Institute
Publications - 171
Citations - 5812
Carolyn E. Mountford is an academic researcher from Translational Research Institute. The author has contributed to research in topics: Nuclear magnetic resonance spectroscopy & In vivo magnetic resonance spectroscopy. The author has an hindex of 44, co-authored 168 publications receiving 5406 citations. Previous affiliations of Carolyn E. Mountford include National Research Council & University of Sydney.
Papers
More filters
Journal ArticleDOI
Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy
Wanda B. Mackinnon,P A Barry,Peter Malycha,D J Gillett,Peter Russell,Cynthia L. Lean,Sinead Doran,Bruce Barraclough,M Bilous,Carolyn E. Mountford +9 more
TL;DR: Proton MR spectroscopy of fine-needle biopsy specimens provides objective diagnostic information that complements findings of conventional preoperative investigations of breast lesions.
Journal ArticleDOI
Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride.
George L. May,Lesley C. Wright,Kerry T. Holmes,Philip G. Williams,I. C. P. Smith,Peter E. Wright,R. M. Fox,Carolyn E. Mountford +7 more
TL;DR: In this paper, a two-dimensional scalar correlated (COSY) NMR spectroscopy was used to identify the high resolution NMR relaxation behavior of nonaqueous components.
Journal ArticleDOI
Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
Reiko Woodhams,Satoko Kakita,Hirofumi Hata,Keiichi Iwabuchi,Masaru Kuranami,Shiva Gautam,Hiroto Hatabu,Shinichi Kan,Carolyn E. Mountford +8 more
TL;DR: In this article, the authors used MR imaging without contrast medium for detection of residual breast cancer after neoadjuvant chemotherapy, and demonstrated that MR imaging with diffusion-weighted contrast medium may provide diagnostic ability equivalent to that of contrast-enhanced MR imaging.
Journal ArticleDOI
Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy.
Carolyn E. Mountford,R. L. Somorjai,Peter Malycha,Laurence Gluch,Cynthia L. Lean,Peter Russell,Bruce Barraclough,D J Gillett,Uwe Himmelreich,Brion Dolenko,Alexander E. Nikulin,I. C. P. Smith +11 more
TL;DR: The aim was to develop robust classifiers to analyse magnetic resonance spectroscopy data of fine‐needle aspirates taken from breast tumours to provide computerized, classification‐based diagnosis and prognostic indicators.
Journal ArticleDOI
Neurospectroscopy: the past, present and future.
TL;DR: Al Alzheimer's disease can now be identified much earlier than before offering earlier management before the disease progresses, and the long-term effect of shaken baby syndrome and traumatic brain injury can be gauged by neurospectroscopy.